跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
美素生 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Methotrexate Injection
Approved
化学药品
Methotrexate Injection
PFIZER AUSTRALIA PTY LTD
🇨🇳 National Medical Products Administration
Approval Date
Apr 23, 2020
Approval ID
81u6Jt4sZfu
Company
PFIZER AUSTRALIA PTY LTD
Type
化学药品
Approval Details
Approval Id
81u6Jt4sZfu
Approval Number
H20090597
Generic Name
甲氨蝶呤注射液
Generic Name En
Methotrexate Injection
Trade Name
美素生
Drug Type
化学药品
Dosage Form
注射剂
Strength
10ml:1g
Reg Date
2020-04-23
Expired Date
2025-04-22
Company Name
PFIZER AUSTRALIA PTY LTD
Company Address
Level 17 151 Clarence Street Sydney NSW 2000 AUSTRALIA
Production Company Name
HOSPIRA AUSTRALIA PTY LTD
Production Company Address
1-5 7-23 and 25-39 Lexia Place MULGRAVE VIC 3170 Australia
Company Detail Path
/organization/pfizer-australia-pty-ltd
Production Company Detail Path
/organization/hospira-australia-pty-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 23, 2020
Approval ID
81u6Jt4sZfu
Type
化学药品
Back to NMPA Approvals